Plunkett Research Online: BioPharmX Corporation

BIOPHARMX CORPORATION (BPMX:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that ar.....



BioPharmX Corporation
Ticker: BPMX
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 889-5020
Fax:
Address: 1505 Adams Drive
Suite D
Menlo Park, CA 94025 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Greg KitchenerCFO/Chief Accounting Officer/Executive VP
Stephen MorlockDirector
See More
BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that ar.....See More See More

Auditor: Burr Pilger Mayer, Inc.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: